Section 32 is a venture capital firm in California that focuses on investing in the healthcare and information technology sectors. Founded 2017 in San Diego, California, United States by Bill Maris, it invests in series A, series B, seed, series C, and secondary markets. It portfolio companies include Cradle Genomics, Vineti, Legacy, XOKind, and Aspen Neuroscience. As of February 2020, Section 32 has made 33 investments. Their most recent investment was on February 9, 2020, when Vineti raised $35M. Section 32 has had three exits, the most notable of which include Auris Health, Alector, and Fulcrum Therapeutics. The company has raised two funds, their latest being Section 32 Fund 2. This fund was announced on February 21, 2019 and raised a total of $199.4M.
Bloom API is a healthcare company focused on communication practices.
An insurance technology company offering automobile insurance at a base rate combined with payments for miles driven.
Primer is a San Francisco-based company founded in 2015 by Sean Gourley developing AI to generate written intelligence reports.
Cardinal Health is a healthcare and medical company that looks to provide cost-effective healthcare
Freenome is a San Francisco-based company which uses genetic analysis for early cancer detection and risk assessment.
A company offering semen analysis and storage services.
Cradle Genomics is a San Diego-based prenatal diagnosis company.
Cue Health is a San Diego-based medical device company working to track health information at the molecular level.
Ciitizen is a Palo Alto, California-based company founded by Anil Sethi.
A medication guidance company personalizing medication experiences for employers, employees and their families
Teckro is a UK-based life science technology company that digitalizes clinical trial data.
Kobalt Music Group is a London-based company in the music industry.
Associated investment funds
Michael J. Pellini
Steven J. Kafka
Documentaries, videos and podcasts
Thrive Earlier Detection